Cook Wealth’s Lisata Therapeutics LSTA Stock Holding History

Cook Wealth’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,175	Closed	-$29.3K	–	33
2025 Q1	$29.3K	Hold	12,175	–	–	0.01%	52
2024 Q4	$29.6K	Hold	12,175	–	–	0.01%	55
2024 Q3	$34.2K	Hold	12,175	–	–	0.02%	54
2024 Q2	$41.8K	Hold	12,175	–	–	0.02%	56
2024 Q1	$35.7K	Hold	12,175	–	–	0.02%	55
2023 Q4	$33.5K	Hold	12,175	–	–	0.02%	53
2023 Q3	$25.1K	Hold	12,175	–	–	0.02%	52
2023 Q2	$38.4K	Hold	12,175	–	–	0.03%	50
2023 Q1	$39.6K	Hold	12,175	–	–	0.03%	46
2022 Q4	$30.8K	Hold	12,175	–	–	0.03%	41
2022 Q3	$51K	Buy	+12,175	New	+$88.3K	0.06%	41

Other funds holding LSTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cook Wealth's LSTA Position: Q2 2025 in Review

Cook Wealth sold out of Lisata Therapeutics (LSTA) in Q2 2025, closing a stake of 12,175 shares — an estimated $29.3K sold.

Cook Wealth first reported a position in LSTA in Q3 2022 and held it in 11 quarters. The position peaked at $51K in Q3 2022. 20 funds tracked by Wall St. Rank hold LSTA as of Q2 2025.

Cook Wealth reported no remaining Lisata Therapeutics position as of Q2 2025 after selling out during the quarter.
Cook Wealth sold 12,175 Lisata Therapeutics shares in Q2 2025, an estimated $29.3K.
Cook Wealth first reported a position in Lisata Therapeutics in Q3 2022 and held it in 11 quarters.
Cook Wealth's Lisata Therapeutics position peaked at $51K in Q3 2022.
20 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2025.

Based on Cook Wealth's 13F filing for Q2 2025.